Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 40,375 | 47,226 | 41,271 | 37,650 | 29,886 |
| Operating Income | -40,375 | -47,226 | -41,271 | -37,650 | -29,886 |
| Other Income | 354 | 43 | -114 | -84 | -626 |
| Pre-tax Income | -40,021 | -47,183 | -41,385 | -37,734 | -30,512 |
| Income Tax | 352 | -12 | N/A | -31 | -41 |
| Net Income Continuous | -40,373 | -47,171 | -41,385 | -37,703 | -30,471 |
| Net Income | $-40,373 | $-47,171 | $-41,385 | $-37,703 | $-30,471 |
| EPS Basic Total Ops | -0.35 | -0.41 | -0.36 | -0.35 | -0.31 |
| EPS Basic Continuous Ops | -0.35 | -0.41 | -0.36 | -0.35 | -0.31 |
| EPS Diluted Total Ops | -0.35 | -0.41 | -0.36 | -0.35 | -0.31 |
| EPS Diluted Continuous Ops | -0.35 | -0.41 | -0.36 | -0.35 | -0.31 |
| EBITDA(a) | $-40,331 | $-47,226 | $-41,271 | $-37,622 | $-29,860 |